Zain Shekhani - Profile and Investment Details

Investor Profile

Zain Shekhani is a Private Equity Firm based in United States with a diverse investment portfolio that includes companies such as HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems, TriVascular, Ceterix Orthopaedics, Omeros, Benvenue Medical, AFT Pharmaceuticals, Outset Medical, Good Start Genetics, BioDelivery Sciences International, Valeritas, Intrinsic TherapeuticsNanoString Technologies, Endoceutics, Harmony Biosciences, GenomeDx Biosciences, Bioniche Pharma Group, Blue Belt Technologies, TearLab Corporation, Exagen, Nevro, Avinger, Strongbridge Biopharma, SOC Telemed, Solta Medical, Corium International, Iroko Pharmaceuticals, Cardiome Pharma, ViewRay, Synergy Pharmaceuticals, Autonomic Technologies, EndoGastric Solutions, US WorldMeds, Biodesix, Silk Road Medical, Tandem Diabetes Care, RainDance Technologies, Earlens Corporation, Hicuity Health, Inc., . Over time, Zain Shekhani has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Zain Shekhani is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Women Founded, Biotechnology, Health Diagnostics, Medical, Pharmaceuticals may find it worthwhile to explore potential connections with Zain Shekhani, as their portfolio suggests a familiarity and interest in this area.

Understanding Zain Shekhani’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.